These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 10734256)
1. Carbamazepine-induced Stevens-Johnson syndrome treated with IV steroids and IVIG. Straussberg R; Harel L; Ben-Amitai D; Cohen D; Amir J Pediatr Neurol; 2000 Mar; 22(3):231-3. PubMed ID: 10734256 [TBL] [Abstract][Full Text] [Related]
2. Spectrum of anticonvulsant hypersensitivity syndrome: controversy of treatment. Lee WC; Leung JL; Fung CW; Chung BH; Wong V J Child Neurol; 2004 Aug; 19(8):619-23. PubMed ID: 15605473 [TBL] [Abstract][Full Text] [Related]
3. Treatment of anticonvulsant hypersensitivity syndrome with intravenous immunoglobulins and corticosteroids. Prais D; Straussberg R; Amir J; Nussinovitch M; Harel L J Child Neurol; 2006 May; 21(5):380-4. PubMed ID: 16901442 [TBL] [Abstract][Full Text] [Related]
4. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases. Chen J; Wang B; Zeng Y; Xu H Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352 [TBL] [Abstract][Full Text] [Related]
5. Stevens-Johnson syndrome developing in a girl with systemic lupus erythematosus on high-dose corticosteroid therapy. Samimi SS; Siegfried E Pediatr Dermatol; 2002; 19(1):52-5. PubMed ID: 11860572 [TBL] [Abstract][Full Text] [Related]
6. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants. Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634 [No Abstract] [Full Text] [Related]
11. Use of intravenous immunoglobulin in children with stevens-johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. Metry DW; Jung P; Levy ML Pediatrics; 2003 Dec; 112(6 Pt 1):1430-6. PubMed ID: 14654625 [TBL] [Abstract][Full Text] [Related]
12. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes. Tan SK; Tay YK Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108 [TBL] [Abstract][Full Text] [Related]
15. Toxic epidermal necrolysis: 13 years of experience in the management at a Department of Dermatology in China. Zhang F; Zhou J Cutan Ocul Toxicol; 2017 Mar; 36(1):19-24. PubMed ID: 27079364 [TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations. Zipitis CS; Thalange N Eur J Pediatr; 2007 Jun; 166(6):585-8. PubMed ID: 17008995 [TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Mittmann N; Chan B; Knowles S; Cosentino L; Shear N Am J Clin Dermatol; 2006; 7(6):359-68. PubMed ID: 17173470 [TBL] [Abstract][Full Text] [Related]
18. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin. Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867 [TBL] [Abstract][Full Text] [Related]